08/06/2020
6:25 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2020
6:14 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2020
4:07 PM | BioCryst Pharmaceuticals (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SC 13G
| |
06/10/2020
3:32 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/10/2020
3:32 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/10/2020
3:31 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/01/2020
7:30 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2020
5:07 AM | BioCryst Pharmaceuticals (Filer)
| Form 424B2
| |
05/27/2020
4:16 PM | BioCryst Pharmaceuticals (Filer)
| Form 424B5
| |
05/15/2020
3:20 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/14/2020
11:15 PM | BioCryst Pharmaceuticals (Filer)
| Form EFFECT
| |
05/14/2020
3:36 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2020
3:21 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2020
3:18 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2020
6:15 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2020
7:55 AM | BioCryst Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/17/2020
4:30 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
BioCryst Pharmaceuticals (Subject)
| Form SC 13G
| |
04/09/2020
7:11 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2020
9:51 AM | BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2020
6:55 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2020
11:53 AM | BioCryst Pharmaceuticals (Filer)
| Form DEFA14A
| |
03/31/2020
11:52 AM | BioCryst Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/30/2020
6:20 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2020
3:15 PM | BioCryst Pharmaceuticals (Filer)
| Form PRE 14A
| |
03/13/2020
2:36 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/10/2020
8:26 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2020
6:24 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2020
6:24 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2020
3:49 PM | BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2020
3:42 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2020
6:05 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2020
4:13 PM | BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
4:11 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
3:57 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
3:53 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
6:07 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
3:20 PM | BioCryst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A
| |
02/14/2020
3:14 PM | BAKER BROS. ADVISORS LP (Filed by)
BioCryst Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/13/2020
12:17 PM | BioCryst Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A
| |
02/03/2020
6:21 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2020
4:01 PM | BioCryst Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G/A
| |
01/21/2020
7:59 AM | BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2020
8:05 AM | BioCryst Pharmaceuticals (Issuer)
Jones Michael L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/15/2020
6:15 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
5:32 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2019
4:13 PM | BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
| Form 4/A
| |
12/26/2019
4:09 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4/A
| |
12/19/2019
4:55 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2019
4:52 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2019
4:49 PM | BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2019
4:47 PM | BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2019
4:36 PM | BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2019
4:34 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2019
6:28 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2019
4:17 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2019
4:14 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2019
4:12 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2019
4:09 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
12:16 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2019
8:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 424B5
| |
11/20/2019
6:59 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2019
3:42 PM | BioCryst Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G
| |
11/18/2019
3:17 PM | BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
3:16 PM | BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
3:14 PM | BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
3:10 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
3:08 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
3:05 PM | Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
3:03 PM | Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
3:01 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
8:36 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2019
4:25 PM | BioCryst Pharmaceuticals (Filer)
| Form 424B2
| |
11/08/2019
3:45 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2019
8:06 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2019
6:31 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2019
6:02 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2019
6:32 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2019
6:37 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2019
6:20 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2019
3:27 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2019
3:25 PM | BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/23/2019
8:45 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2019
7:38 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2019
3:16 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
3:14 PM | ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
3:12 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
3:08 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2019
3:08 PM | BioCryst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2019
6:45 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2019
12:25 PM | BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2019
8:21 AM | BioCryst Pharmaceuticals (Issuer)
Sniecinski Megan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/01/2019
7:07 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2019
6:41 AM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2019
3:29 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2019
3:02 PM | BioCryst Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/04/2019
2:00 PM | BioCryst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2019
3:23 PM | BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:21 PM | BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:19 PM | BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
3:16 PM | BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
